Real-world Utilization of SARS-CoV-2 Serological Testing in RNA Positive Patients Across the United States

September 1, 2022 FDA Covid-19

Data lag in a large open and closed claims dataset: Navigating the completeness-timeliness tradeoff

September 1, 2022 Aetion Other

Vital Signs: Hepatitis C Treatment Among Insured Adults

August 9, 2022 CDC Other

Post–COVID-19 Symptoms and Conditions Among Children and Adolescents

August 5, 2022 CDC COVID-19

Categorization of COVID-19 severity to determine mortality risk

April 4, 2022 NIH COVID-19

Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge

March 17, 2022 JAMA Network COVID-19

Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021

January 14, 2022 CDC COVID-19

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

October 12, 2021 medRxiv COVID-19

Comparative Effectiveness Of Remdesivir Treatment In Patients Hospitalized With Covid-19

June 20, 2021 ASM COVID-19

Categorization of COVID-19 Severity to Determine Mortality Risk

May 26, 2021 FDA COVID-19

Temporal trends in medication utilization among hospitalized COVID-19 patients

May 26, 2021 FDA COVID-19

Clinical Burden and Practice Patterns in Patients With Chronic Hypoparathyroidism in the United States (US): A Claims Data Analysis Using Diagnosis-Based Criteria

March 20, 2021 Amolyt Pharma Rare disease

COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients

March 17, 2021 PLOS COVID-19

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection

February 24, 2021 JAMA Network COVID-19

Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection

December 20, 2020 medRxiv COVID-19

Diagnosis-wide analysis of COVID-19 complications: An exposure-crossover study

December 8, 2020 CMAJ COVID-19

Diagnosis-wide analysis of COVID-19 complications: An exposure-crossover study” (reference no. CMAJ-20-1686.R2)

December 08, 2020 CMAJ COVID-19

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 240,392 patients hospitalized with COVID-19 in the United States

November 27, 2020 NIH COVID-19

Comorbid Medical Conditions, Outpatient Healthcare Resource Use, and Charges Associated with Diagnosis of Chronic Insomnia in the US

October 19, 2020 UNC Charlotte Neurology

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

October 01, 2020 Science Magazine COVID-19

Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US

July 1, 2020 PLOS COVID-19

Health Resource Utilization in Advanced Ovarian and Endometrial Cancer in a United States Insurance Claims Database

November 02, 2019 Medidata Oncology

Prescription Pattern & Physician Propensity for Congestive Heart Failure Treatments in United States & Europe

November 02, 2019 Medidata Cardiology

Scalable Prediction of Cancer Patient Clinical Events in Real-World Clinical Settings

November 01, 2019 Medidata Oncology

Using Clinical Data Standards to Facilitate Comparisons of Acute Myeloid Leukemia Treatment Patterns and Outcomes in Real-World Clinical Care and Pooled Clinical Trial Populations

November 01, 2019 Medidata Oncology

Predicting Chemotherapy-associated Thrombocytopenia In Real World Clinical Settings

August 01, 2019 Medidata Oncology

Real World Replication Of Clinical Trial Findings In Alzheimer’s Disease

August 01, 2019 Medidata Neurology